Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trials
Animal models and observational human data indicate that complement, including C5a, pathogenically participates in ischemia reperfusion (IR) injury that manifests as delayed graft function (DGF) following deceased donor kidney transplantation. We report on the safety/efficacy of anti-C5 monoclonal a...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Langue: | anglais |
Publié: |
2019
|
Accès en ligne: | https://doi.org/10.1111/ajt.15580 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ajt.15580 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Soyez le premier à ajouter un commentaire!